New cause of glaucoma identified

15 September 2014

New research has identified a previously unknown cause of glaucoma, which is a leading cause of irreversible blindness.

The condition is associated with elevated pressure on the eye, which is usually caused by a blockage, but the source of this is not understood or what prevents the eye from draining the build up of fluid.

A study, published in the journal Proceedings of the National Academy of Sciences (PNAS), was led by a biomedical engineer at Northwestern University and determined that glaucoma appears to result from a mechanical dysfunction of endothelial cells. This thin cell is the final barrier that stops fluid entering Schlemm’s canal, and allows liquid to be drained from the eye.

During the research using human ocular cells, the team found that endothelial cells from eyes with glaucoma are stiffer than those from healthy organs. This rigidity prevents the cells from being able to deform and allow a fluid called aqueous humour to cross the endothelium and drain into Schlemm’s canal. This flow resistance causes the elevated pressure associated with glaucoma. 

Posted by Edward Bartel​


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)